Skip to main content
Mabion S.A. logo

Mabion S.A. — Investor Relations & Filings

Ticker · MAB ISIN · PLMBION00016 LEI · 259400KG5JVQPPZL6X53 WAR Manufacturing
Open in API
Filings indexed 1,002 across all filing types
Latest filing 2020-06-15 AGM Information
Country PL Poland
Listing WAR MAB

About Mabion S.A.

https://www.mabion.eu/en/

Mabion S.A. is an integrated Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services for the development and manufacturing of protein-based biotherapeutics. The company specializes in monoclonal antibodies and biosimilars, offering a complete workflow from cell line development and banking to process optimization and large-scale GMP manufacturing. Core competencies include upstream processing using mammalian cell cultures, downstream purification involving chromatography and viral clearance, and technology transfer for scale-up. Mabion partners with pharmaceutical and biotechnology companies to support both clinical and commercial supply, streamlining the path from gene to final drug product.

Recent filings

Filing Released Lang Actions
Tresc_uchwal_ZWZ_Mabion_SA_z_15.06.2020.
AGM Information Classification · 100% confidence The document text is titled "TREŚĆ UCHWAŁ ZWYCZAJNEGO WALNEGO ZGROMADZENIA MABION S.A. Z DNIA 15 CZERWCA 2020 ROKU" (Content of Resolutions of the Annual General Meeting of Mabion S.A. of June 15, 2020). It explicitly details multiple resolutions (Uchwała nr 1/VI/2020 through Uchwała nr 9/VI/2020) passed during a General Meeting, including the approval of the 2019 financial statements and granting discharge (absolutorium) to management board members. This content directly corresponds to the documentation produced at an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information).
2020-06-15 Polish
Treść uchwał Zwyczajnego Walnego Zgromadzenia Mabion S.A. z dnia 15 czerwca 2020 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document text is very short (437 characters) and explicitly states that the Management Board ('Zarząd') is attaching the content of the resolutions ('treść uchwał') adopted by the Ordinary General Meeting ('Zwyczajne Walne Zgromadzenie Spółki') held on June 15, 2020. This indicates the document is an announcement about the results of the shareholder vote, rather than the full minutes or the AGM presentation itself. The most fitting category for official results from a general meeting is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it mentions the AGM, the core content is the result of the voting.
2020-06-15 Polish
Mabion_Pozostale_Informacje_do_Raportu Kwartalnego_Q1_2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Pozostałe informacje do raportu kwartalnego Mabion S.A. za I kwartał 2020 roku' (Other information for the quarterly report of Mabion S.A. for Q1 2020). It contains detailed financial data (balance sheet, income statement, cash flow), management discussion, and corporate governance information for a specific fiscal period (Q1 2020). This fits the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-25 Polish
Mabion_MSSF 2020 Q1
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial report ('Śródroczne Skrócone Sprawozdanie Finansowe') for Mabion S.A. covering the 3-month period ending March 31, 2020. It contains comprehensive financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, Statement of Cash Flows, and Statement of Changes in Equity. As it provides substantive financial data for an interim period, it is classified as an Interim/Quarterly Report. Q1 2020
2020-05-25 Polish
Podjęcie decyzji o zamiarze przeprowadzenia emisji akcji w celu podwyższenia kapitału zakładowego Mabion S.A. - Content (EN)
Capital/Financing Update Classification · 98% confidence The document explicitly discusses the Management Board's decision regarding the 'intention to issue U series ordinary bearer shares of the Company in order to increase the share capital'. This action directly relates to changes in the company's capital structure and fundraising activities. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it mentions proposing an item for the Ordinary General Meeting (AGM), the primary subject is the capital increase decision itself, not the AGM materials or voting results.
2020-05-19 English
Podjęcie decyzji o zamiarze przeprowadzenia emisji akcji w celu podwyższenia kapitału zakładowego Mabion S.A. - Content (PL)
Capital/Financing Update Classification · 98% confidence The document text explicitly states the Management Board's decision ('Zarząd Mabion S.A. ... podjął decyzję o zamiarze przeprowadzenia emisji do 1.907.281 akcji zwykłych na okaziciela serii U Spółki o wartości nominalnej 0,10 zł każda, w celu podwyższenia kapitału zakładowego Spółki'). This clearly indicates an intention to raise capital through the issuance of new shares. This action falls directly under the definition of Capital/Financing Update (CAP). Although it mentions a future General Meeting (Zwyczajnego Walnego Zgromadzenia), the core subject is the planned share issuance for financing development (MabionCD20). It is not a general announcement of a report (RPA) but the substance of a financing decision.
2020-05-19 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.